Liraglutide: A New Option for the Treatment of Obesity.

@article{Nuffer2015LiraglutideAN,
  title={Liraglutide: A New Option for the Treatment of Obesity.},
  author={Wesley Nuffer and Jennifer M Trujillo},
  journal={Pharmacotherapy},
  year={2015},
  volume={35 10},
  pages={
          926-34
        }
}
Obesity continues to pose a major public health risk to the United States and across the world, with an estimated one-third of adult Americans being defined as obese. Obesity treatment guidelines recommend the use of pharmacologic therapy in adults who have a body mass index (BMI) of 30 kg/m(2) or higher or in patients with a BMI of 27 kg/m(2) or higher who have at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, insulin resistance, type 2 diabetes mellitus… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Similar Papers

Loading similar papers…